Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    A June 3, 2026 news release about MDNA11 in earlier-line melanoma is added; the April 30, 2026 NEOCYT ASCO release is removed.
    Difference
    3%
    Check dated 2026-06-05T09:11:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Two new news items were added to the News Releases page: May 28, 2026, announcing the closing of a public offering of units to raise CDN$4.44 million. May 22, 2026, announcing the filing of a prospectus supplement and investment term sheet.
    Difference
    4%
    Check dated 2026-05-29T07:39:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A new press release dated May 19, 2026 announcing the finalization of the terms of Medicenna's public offering of securities was added to the News Releases page. The April 9, 2026 entry announcing Dr. Nageatte Ibrahim as Chief Medical Officer was removed.
    Difference
    3%
    Check dated 2026-05-22T09:41:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Two new News Releases were added for May 13, 2026 and May 12, 2026, announcing a marketed public offering and the first patient dosed in the NEO-CYT study of MDNA11 in Neoadjuvant Melanoma. Two older releases from February and March 2026 were removed, updating the page to reflect current corporate actions and trial milestones.
    Difference
    3%
    Check dated 2026-05-15T05:19:15.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new news release entry dated April 30, 2026 about Medicenna and Fondazione Melanoma Onlus announcing presentation on NEOCYT Trial at ASCO 2026 has been added. The February 13, 2026 press release concerning Q3 FY2026 financial results and a corporate update has been removed.
    Difference
    3%
    Check dated 2026-04-30T19:36:50.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The news releases listing was updated: a new April 21, 2026 item about Medicenna presenting positive AACR 2026 data for its MDNA113 superkine was added, while older items (including a board-composition related update and an February 13, 2026 listing) were removed.
    Difference
    4%
    Check dated 2026-04-23T21:56:23.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.